Loading…
Lobbying Spend
—
Filings
20
Firms Hired
1
Active Period
2022–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Health and pharmaceutical policies before the Congress. S. 4348, FDASLA Act of 2022, all provisions related to fees related to generic drugs.
Client expense: — · Firm income: $30,000
Matched citations: S. 4348
Health and pharmaceutical policies before the Congress and the Administration. S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act, all provisions related to supply chain for medical products and mitigating U.S. medicine shortages
Client expense: — · Firm income: $30,000
Matched citations: S. 3799
Source: Senate LDA